Teva Pharmaceutical Industries Limited (TEVA) Discusses Duvakitug IBD Phase 2b Maintenance Top-Line Results Transcript
Source: SeekingAlpha
2026-02-17 10:54:57 ET
Teva Pharmaceutical Industries Limited (TEVA) Discusses Duvakitug IBD Phase 2b Maintenance Top-Line Results February 17, 2026 8:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
Teva Pharmaceutical Industries Limited (TEVA) Discusses Duvakitug IBD Phase 2b Maintenance Top-Line Results Transcript
Teva Pharmaceutical Industries Ltd
NASDAQ: TEVJF
TEVJF Trading
43530.77% G/L:
$28.36 Last:
100 Volume:
$28.36 Open:
TEVJF Latest News
June 06, 2025 09:44:00 am
Teva 2024 Healthy Future Report: Health System Strengthening and Capacity Building
TEVJF Stock Data
$39,634,050,594
1,138,314,769
N/A
264
N/A
Pharmaceuticals
Healthcare
IL
Tel Aviv
